We recently traveled to New York City for a State of the Science Summit™ on Breast Cancer. During the meeting, faculty from the Icahn School of Medicine of Mount Sinai Health System, as well as Columbia University Medical Center, discussed the latest updates in the rapidly evolving paradigms of triple-negative breast cancer, HER2-positive breast cancer, hormone receptor-positive, HER2-negative disease, and more.